Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2026-05-14 16:17:02 ET · period of report 2026-05-13 · accession 0001178670-26-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-14 16:17 | 2026-05-13 | ALNY | SCHULMAN AMY W | Dir | M - OptEx | $70.20 | +11.2K | 23.2K | +94% | +$789.8K |
| D | 2026-05-14 16:17 | 2026-05-13 | ALNY | SCHULMAN AMY W | Dir | M - OptEx | $0.00 | -11.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-13 | M | A | 11,250 | $70.20 | 23,211 | D | — | — | (F1) The options exercised and held by the reporting person were due to expire on June 3, 2026. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-13 | M | D | 11,250 | $0.00 | 0 | D | $70.20 · 2017-06-03 to 2026-06-03 | 11,250 Common Stock | (F1) The options exercised and held by the reporting person were due to expire on June 3, 2026. |